Menstrual Cycle Characteristics of Healthcare Professionals

November 18, 2020 updated by: Sevcan Arzu Arinkan, Haydarpasa Numune Training and Research Hospital

Menstrual Cycle Characteristics of Healthcare Professionals at Covid 19 Pandemic Hospital

The Covid-19 pandemic has impacted healthcare workers physically and psychologically. The aim of this study is to examine whether there is a change in menstrual cycle characteristics during pandemia. The aim of this study is to investigate whether there is an association between covid infection and menstrual cycle changes.

Study Overview

Status

Completed

Detailed Description

The Covid-19 pandemic has impacted healthcare workers physically and psychologically. Healthcare workers have ben required to work under stressful conditions and take difficult decisions involving ethical implications. Increasing work demands on healthcare professionals conflict with their duties to family and friends, which causes psychological stress. All of these factors may negatively affect their menstrual cycle.

The aim of this study is to examine whether there is a change in menstrual cycle characteristics during pandemia. Second aim is to investigate whether there is an association between Covid 19 infection and menstrual cycle changes.

This cross-sectional study is conducted with healthy female participants who are working at Haydarpasa Numune Research and Training Hospital in Turkey. The researcher investigates the characteristics of menstrual cycle in female healthy workers employed in Covid 19 pandemic inpatient and outpatient clinics. The participants who are sure about their pertinent information are enrolled in the study. The exclusion criteria includes pregnancy, history of hysterectomy, oophorectomy, diseases like Asherman's syndrome and also history of endocrine disorders (progesterone deficiency, thyroid disorders and diabetes mellitus), oral contraceptive use, malignancy, primary amenorrhea, menopause and lactation.

After informed consent, detailed information is collected using structured questionnaires about their reproductive factors and menstrual cycles by direct interviews. The questionnaire contains questions about age, work experience, marital status, height, weight, working hours, use of medication, menstrual cycle characteristics (including cycle duration, duration and amount of bleeding, bleeding during the cycle, regular or irregular menstrual cycles) and dysmenorrhea. Also, the difference in menstrual cycle characteristics between covid positive and negative healthcare professionals is investigated.

Study Type

Observational

Enrollment (Actual)

260

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • University of Health Sciences Turkey

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 47 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Healthy female healthcare workers at Covid 19 pandemic hospital

Description

Inclusion Criteria:

  • Working at Covid 19 Pandemic Hospital
  • Being at between 18 and 47 years old
  • Having menstruation

Exclusion Criteria:

  • Oral contraceptive users
  • Pregnants
  • Having malignancy
  • Having primary amenorrhea
  • Being at menopause
  • Lactation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Female healthcare workers
Healthy female healthcare workers at Covid 19 clinic in Istanbul, Turkey

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of irregular menstrual cycle
Time Frame: 1 month after starting to work at pandemic clinic
Irregular menstrual cycle
1 month after starting to work at pandemic clinic
Length of cycle
Time Frame: 1 month after starting to work at pandemic clinic
Length of cycle (day)
1 month after starting to work at pandemic clinic
Rate of prolonged bleeding
Time Frame: 1 month after starting to work at pandemic clinic
Duration of bleeding (day)
1 month after starting to work at pandemic clinic
Amount of flow
Time Frame: 1 month after starting to work at pandemic clinic
Number of used tampons during bleeding
1 month after starting to work at pandemic clinic
Rate of dysmenorrhea
Time Frame: 1 month after starting to work at pandemic clinic
Dysmenorrhea status
1 month after starting to work at pandemic clinic

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of difference in menstrual cycle length
Time Frame: Up to 1 month after covid infection
Menstrual cycle difference between covid positive and negative healthcare workers (days)
Up to 1 month after covid infection
The number of difference in bleeding days
Time Frame: Up to 1 month after covid infection
Duration of bleeding difference between covid positive and negative healthcare workers (days)
Up to 1 month after covid infection
The number of difference in amount of flow
Time Frame: Up to 1 month after covid infection
Amount of flow difference between covid positive and negative healthcare workers (tampons)
Up to 1 month after covid infection

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2020

Primary Completion (Actual)

September 10, 2020

Study Completion (Actual)

September 10, 2020

Study Registration Dates

First Submitted

May 27, 2020

First Submitted That Met QC Criteria

May 31, 2020

First Posted (Actual)

June 2, 2020

Study Record Updates

Last Update Posted (Actual)

November 19, 2020

Last Update Submitted That Met QC Criteria

November 18, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Menstrual Irregularity

3
Subscribe